CENCORA INC (COR) Stock Price, Quote, News and Overview
NYSE:COR - New York Stock Exchange, Inc. - US03073E1055 - Common Stock - Currency: USD
COR Quote, Performance and Key Statistics
241.43
-2.03 (-0.83%)
The current stock price of COR is 241.43 USD. In the past month the price decreased by -2.63%. In the past year, price increased by 1.75%.
COR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 20.5 | 74.91B | ||
| CAH | CARDINAL HEALTH INC | 16.44 | 30.69B | ||
| HSIC | HENRY SCHEIN INC | 18.35 | 9.59B | ||
| PDCO | PATTERSON COS INC | 14.66 | 2.74B | ||
| AHCO | ADAPTHEALTH CORP | N/A | 1.14B | ||
| AHG | AKSO HEALTH GROUP | N/A | 518.47M | ||
| OMI | OWENS & MINOR INC | 3.75 | 479.62M | ||
| COSM | COSMOS HEALTH INC | N/A | 14.34M | ||
| VRAX | VIRAX BIOLABS GROUP LTD | N/A | 8.12M | ||
| ATPC | AGAPE ATP CORP | N/A | 3.73M |
Related stock screener links
About COR
Company Profile
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania. The firm is focused on improving the lives of people and animals around the world. The company is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Company Info
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA 80202 US
CEO: Paul E. Szurek
Employees: 44000
Company Website: https://www.cencora.com/
Investor Relations: https://investor.amerisourcebergen.com
Phone: 16107277000
CENCORA INC / COR FAQ
What is the stock price of CENCORA INC today?
The current stock price of COR is 241.43 USD. The price decreased by -0.83% in the last trading session.
What is the ticker symbol for CENCORA INC stock?
The exchange symbol of CENCORA INC is COR and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is COR stock listed?
COR stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for CENCORA INC stock?
22 analysts have analysed COR and the average price target is 275.7 USD. This implies a price increase of 14.2% is expected in the next year compared to the current price of 241.43. Check the CENCORA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CENCORA INC worth?
CENCORA INC (COR) has a market capitalization of 46.77B USD. This makes COR a Large Cap stock.
How many employees does CENCORA INC have?
CENCORA INC (COR) currently has 44000 employees.
What are the support and resistance levels for CENCORA INC (COR) stock?
CENCORA INC (COR) has a support level at 241.33 and a resistance level at 254.22. Check the full technical report for a detailed analysis of COR support and resistance levels.
Is CENCORA INC (COR) expected to grow?
The Revenue of CENCORA INC (COR) is expected to grow by 9.66% in the next year. Check the estimates tab for more information on the COR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CENCORA INC (COR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of COR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of COR, evaluating the profitability, health, valuation and growth aspects
- CENCORA INC (COR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CENCORA INC (COR) Sales and EPS estimates to see what analysts future expectations are.
- CENCORA INC (COR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CENCORA INC (COR) Insider and Institutional Ownership to learn about the owners and their transactions.
- CENCORA INC (COR) Stock Chart to make your own analysis
- CENCORA INC (COR) Latest news and press-releases to stay up to date.
Does CENCORA INC (COR) stock pay dividends?
CENCORA INC (COR) has a dividend yield of 0.9%. The yearly dividend amount is currently 2.1. Check the full fundamental report for a detailed analysis of COR dividend history, reliability and sustainability.
When does CENCORA INC (COR) report earnings?
CENCORA INC (COR) will report earnings on 2025-04-29, after the market close.
What is the Price/Earnings (PE) ratio of CENCORA INC (COR)?
The PE ratio for CENCORA INC (COR) is 16.99. This is based on the reported non-GAAP earnings per share of 14.21 and the current share price of 241.43 USD. Check the full fundamental report for a full analysis of the valuation metrics for COR.
What is the Short Interest ratio of CENCORA INC (COR) stock?
The outstanding short interest for CENCORA INC (COR) is 4.99% of its float. Check the ownership tab for more information on the COR short interest.
COR Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to COR. When comparing the yearly performance of all stocks, COR turns out to be only a medium performer in the overall market: it outperformed 43.42% of all stocks.
COR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to COR. COR has a medium profitability rating, but doesn't score so well on its financial health evaluation.
COR Financial Highlights
Over the last trailing twelve months COR reported a non-GAAP Earnings per Share(EPS) of 14.21. The EPS increased by 13.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.46% | ||
| ROA | 2.02% | ||
| ROE | 616.22% | ||
| Debt/Equity | 26.2 |
COR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 77% to COR. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of 13.02% and a revenue growth 9.66% for COR